BUSINESS● LOW1h ago · Sep 4, 2026, 9:00 PM
Ionis Pharmaceuticals falls after Pelacarsen fails key Phase 3 heart trial
Seeking Alpha Tech · global
Ionis Pharmaceuticals experienced a decline after its drug Pelacarsen failed a key Phase 3 heart trial, impacting the company's market performance and drug development efforts.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS19m agoLed by Quintana Roo, Mexico’s tourism GDP ranks fourth globally, according to the World Travel & Tourism CouncilMexico News DailyBUSINESS23m agoTalk is growing of a Tesla-SpaceX merger. Will geopolitics throw a spanner in the works?South China Morning PostBUSINESS34m agoStardust Solar Energy launches $641,000 private placementSeeking Alpha TechBUSINESS36m agoNaira appreciates to N1,395/$ in parallel marketVanguard Nigeria